[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.87.114.118. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 626
Citations 0
Comment & Response
May 3, 2016

Noninvasive Ventilation and Outcomes Among Immunocompromised Patients

Author Affiliations
  • 1CHU de Poitiers, Medical Intensive Care Unit, Poitiers, France
JAMA. 2016;315(17):1901-1902. doi:10.1001/jama.2016.0674

To the Editor The use of noninvasive ventilation as first-line therapy for immunocompromised patients with acute respiratory failure remains controversial.1,2 Dr Lemiale and colleagues3 reported the largest randomized clinical trial to date (374 immunocompromised patients) with the aim of assessing whether noninvasive ventilation could improve outcomes. No difference was found between patients treated with oxygen therapy alone or with noninvasive ventilation.

First Page Preview View Large
First page PDF preview
First page PDF preview
×